MEGAN JOESTING: Open Payments
NPI 1366895351 · DAMASCUS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 30 payments from 11 companies in 2025. Trend: 2023 $561 · 2024 $820 · 2025 $755
Food & beverage: $655Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 10 | $154 |
| Janssen Biotech, Inc. | 2 | $147 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| GENZYME CORPORATION | 2 | $65 |
| Arcutis Biotherapeutics, Inc. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| ABBVIE INC. | 3 | $57 |
| Galderma Laboratories, L.P. | 1 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Amgen Inc. | 1 | $26 |
Products named: DUPIXENT, OPZELURA, TREMFYA, Zoryve, Sotyktu, RINVOQ, NEMLUVIO, COSENTYX.
Industry payments across MD — which companies pay providers there.
